Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,805,918
  • Shares Outstanding, K 41,297
  • Annual Sales, $ 337,280 K
  • Annual Income, $ -470 K
  • 60-Month Beta 1.47
  • Price/Sales 5.44
  • Price/Cash Flow 46.48
  • Price/Book 5.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.11
  • Number of Estimates 6
  • High Estimate 0.21
  • Low Estimate 0.02
  • Prior Year 0.07
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.64 +22.70%
on 04/18/19
49.50 -11.66%
on 05/03/19
+7.16 (+19.58%)
since 04/17/19
3-Month
35.07 +24.69%
on 03/08/19
49.50 -11.66%
on 05/03/19
+3.05 (+7.50%)
since 02/15/19
52-Week
30.00 +45.77%
on 06/28/18
55.00 -20.49%
on 11/02/18
+8.83 (+25.30%)
since 05/17/18

Most Recent Stories

More News
Pacira Pharmaceu Falls 2.81% on Heavy Volume: Watch For Potential Rebound

Pacira Pharmaceu (NASDAQ:PCRX) traded in a range yesterday that spanned from a low of $45.28 to a high of $45.61. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of...

PCRX : 43.73 (-1.58%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (OMER , PCRX , LCI , MDCO , ZGNX )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

LCI : 6.00 (+1.35%)
PCRX : 43.73 (-1.58%)
OMER : 18.64 (-2.25%)
Pacira BioSciences to Present at Two Healthcare Conferences in May

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the following two healthcare conferences:

PCRX : 43.73 (-1.58%)
Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures

- TAP block with EXPAREL provides significant reductions in opioids and pain scores -

PCRX : 43.73 (-1.58%)
Shares of Theravance B Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (TBPH , PCRX , MNK , MYL , ENDP )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

TBPH : 20.62 (-0.10%)
MNK : 14.68 (-3.17%)
PCRX : 43.73 (-1.58%)
Pacira (PCRX) Misses Q1 Earnings Estimates

Pacira (PCRX) delivered earnings and revenue surprises of -8.33% and 0.28%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 43.73 (-1.58%)
Pacira: 1Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a loss of $2.8 million in its first quarter.

PCRX : 43.73 (-1.58%)
Pacira BioSciences Reports First Quarter 2019 Revenues of $91.3 Million

-- EXPAREL(R) net product sales of $90.6 million up 22.4 percent over prior year first quarter --

PCRX : 43.73 (-1.58%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (PCRX , LCI , PRGO , ENDP , HZNP )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

LCI : 6.00 (+1.35%)
PCRX : 43.73 (-1.58%)
PRGO : 49.67 (-0.46%)
Pacira Pharmaceu Rises 15.39% on Heavy Volume: Watch For Potential Pullback

Pacira Pharmaceu (NASDAQ:PCRX) traded in a range yesterday that spanned from a low of $39.41 to a high of $45.98. Yesterday, the shares gained 15.4%, which took the trading range above the 3-day high...

PCRX : 43.73 (-1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade PCRX with:

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

2nd Resistance Point 45.12
1st Resistance Point 44.43
Last Price 43.73
1st Support Level 43.29
2nd Support Level 42.84

See More

52-Week High 55.00
Fibonacci 61.8% 45.45
Last Price 43.73
Fibonacci 50% 42.50
Fibonacci 38.2% 39.55
52-Week Low 30.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar